Insights On Enterprise Solutions
-
Developing Injectable Drug Placebo Formulations For Clinical Trials
1/9/2024
Developing a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
Clear MRSA Infections At Single Low Doses
1/4/2024
Multidrug-resistant bacteria are rendering antibiotics ineffective. Review preclinical results of a potent macrocycle derivative and why collaboration is crucial to transition discoveries into treatments.
-
Cell Line Development: The Linchpin In Successful Biotherapeutic Development
1/4/2024
Review key factors for building a reliable CLD strategy and learn how the right CDMO can help you achieve the high quality, high yield, and speed needed to successfully bring a biologic to market.
-
Real-Time Live Cell Imaging In Successful ADC Development
1/4/2024
Learn how the visualization of critical cellular responses can enable live-cell imaging to indicate effective payload delivery, increasing the potential of identifying clinically viable ADC leads.
-
The MAPPs Assay: A Useful Tool For The Assessment Of Immunogenicity
1/4/2024
Explore how MAPPS demonstrates promise as a valuable tool for comprehensive immunogenicity assessment in therapeutic protein development, contributing to safer and more effective biologics.
-
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
12/27/2023
A new year marks a fresh start for biotech partnerships, and to kick off 2024, we're highlighting a good one. Fina Biosolutions' Dr. Andrew Lees recently signed on with Scorpius BioManufacturing to support his company's growth plan. On the Business of Biotech, Lees sits down with Scorpius VP of commercial operations Steve Lavezoli for a frank conversation on the ups, downs, and expectations of a biotech + CDMO relationship. If you're considering signing on with an outsourced manufacturing partner, or thinking about making a switch, you won't want to miss this episode.
-
Biotech Down Under with BiomeBank's Dr. Sam Costello
12/20/2023
Merry Christmas, Business of Biotechers! On this Christmas Day release, we’re taking a trip to the land down under to visit with Dr. Sam Costello, managing director and co-founder at Adelaide, Australia-based BiomeBank. We covered some ground on this one, most notably the unique path BiomeBank took to chalking up the first donor-derived microbiome therapeutic approval of its kind, anywhere in the world. In a segment of biotech that’s been particularly battered of late, that’s a big, big win.
-
6 Questions To Ask Your Fluid Management Component Supplier
12/19/2023
To ensure you receive the best and safest single-use components, evaluate your fluid management supplier by asking these six questions.
-
What Is Surge Manufacturing And How Can Biopharma Companies Prepare For It?
12/19/2023
In the wake of the pandemic, many pharmaceutical companies are looking into if and how they can perform a rapid scale-up of manufacturing called surge manufacturing.
-
High-Quality Serum to Improve Performance And Supply Stability
12/18/2023
A consultative partnership brought valuable solutions to a global CDMO that was experiencing performance issues with their fetal bovine serum, and needed a new product source of superior quality fast.